Middle East North Africa - Financial Network

Demand More is a registered trade mark of MENAFN.COM

 
  Quotes: US MENA   Enter Symbol: NewsLetter: Search: advanced

USA Market Data: Merck & Co Inc New - MRK




Stock data

Last Trade  56.05 Trade Time  4/15/2014 4:00:00 PM
Change   0 Volume (thou)   3.2
%Change  .00% Last Trade Size  
Open  0 Bid  56.4
Today's High  0 Ask  56.5
Today's Low  0 Size Bid/Ask  2 x1

Fundamental Data

Market Cap (mil)   164821863.1 52 Week High  58.14
Shrs Outstanding (thou)   52 Week Low  44.60
EPS  1.47 PE Ratio  38.13
Volatility   Yield  3.14
Dividend Freq.  4 Ex-Dividend Date  3/13/2014
Dividend Amount  0.44 Exchange  NYSE
Delayed quotes powered by S&P comstock. All stock quotes are delayed by 20 minutes and are believed to be accurate but are not warranted or guaranteed by MENAFN.com

  Related News
Apr 14, 2014 ALK announces FDA approval for Merck's grass sublingual allergy immunotherapy tablet GRASTEK(r) (GRAZAX(r)), GlobeNewswire
Apr 11, 2014 John Daly, Worked With Merck & White House, Receives 5 Stars on Amazon, Marketwire
Apr 10, 2014 Merck renews commitment to the education of tomorrow's scientific innovators, CNW Group
Apr 09, 2014 Engerix-B (Prophylactic Hepatitis B Virus Vaccines) - Forecast and Market Analysis to 2022, New Report Launched, M2
Apr 07, 2014 Prof. pushes for release of Vioxx documents, University Wire
Apr 03, 2014 Merck Canada announces $2-million grant to support personalized treatment in cancer, CNW Group
Mar 31, 2014 New Global Initiative Aims to Improve Patient Outcomes in Metastatic Colorectal Cancer, CNW Group
Mar 27, 2014 Merck Executive Wins EnergySMART Energy Innovator Award, GlobeNewswire
Mar 21, 2014 3D Eye Solutions Inc. Would Like to Announce the Appointment Of Our New CEO Barrett Bott, Marketwire
Mar 18, 2014 Merck expands cancer drug access, but too late for Denver dad Nick Auden, United Press International
Mar 18, 2014 Ligand Pharmaceuticals triggers USD1m milestone payment upon US FDA's approval of Merck's NOXAFIL Injection, M2
Mar 17, 2014 Merck wins US FDA approval for NOXAFIL (posaconazole) Injection (18 mg/mL) for intravenous use, M2
more...

 
 

Middle East North Africa - Financial Network

MENAFN News Market Data Countries Tools Section  
 

Middle East North Africa - Financial Network
Arabic MENAFN

Main News
News By Industry
News By Country
Marketwatch News
UPI News
Comtex News

IPO News
Islamic Finance News
Private Equity News

How-To Guides
Technology Section

Travel Section

Search News

Market Indices
Quotes & Charts

Global Indices
Arab Indices

US Markets Details

Commodoties

Oil & Energy

Currencies Cross Rates
Currencies Updates
Currency Converter

USA Stocks
Arab Stocks
 

Algeria 
Bahrain 
Egypt 
Iraq
Jordan 
Kuwait 
Lebanon
Morocco 
Oman 
Palestine
Qatar 
Saudi Arabia 
Syria
Tunisia 
UAE 
Yemen

Weather
Investment Game
Economic Calendar
Financial Glossary

My MENAFN
Portfolio Tracker

Voting

Financial Calculators

RSS Feeds [XML]

Corporate Monitor

Events

Real Estate
Submit Your Property

Arab Research
Buy a Research

Press Releases
Submit your PR

Join Newsletters


 
© 2000 menafn.com All Rights Reserved.  Terms of Service | Privacy Policy | Contact Us | Advertise | About MENAFN | Career Opportunities | Feedback | Help